Gastric Adenocarcinoma Surgery and Adjuvant Therapy
Authors:
- David A. KoobyDKDavid A. Kooby
- 1 October 2011
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 91 (5) , 1039-1077
Abstract
No abstract availableKeywords
This publication has 185 references indexed in Scilit:
- Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: A retrospective analysisEuropean Journal of Surgical Oncology, 2011
- Sentinel lymph node biopsy in gastric cancer: Possible applications and limitsEuropean Journal of Surgical Oncology, 2011
- The extent of lymph node dissection for gastric cancer: A critical appraisalJournal of Surgical Oncology, 2010
- Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancerClinical and Experimental Medicine, 2010
- Family history of cancer and stomach cancer riskInternational Journal of Cancer, 2008
- Ratio of metastatic lymph nodes: Impact on staging and survival of gastric cancerEuropean Journal of Surgical Oncology, 2008
- Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopyBritish Journal of Cancer, 2007
- Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trialEuropean Journal of Surgical Oncology, 2004
- Should systematic lymph node dissection be recommended for gastric cancer? Pro:European Journal of Cancer, 1998
- Positive results of adjuvant mitomycin-C in resected gastric cancer: A randomised trial on 134 patientsEuropean Journal of Cancer, 1993